BI

BVF Inc Portfolio holdings

AUM $2.97B
1-Year Est. Return 167.08%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+167.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$495M
AUM Growth
-$71.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$30.1M
2
+$22.6M
3
+$17.3M
4
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$8.2M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$4.3M

Top Sells

1
+$10.4M
2
+$9.68M
3
+$5.98M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$4.53M
5
ATXS
Astria Therapeutics
ATXS
+$2.75M

Sector Composition

1 Healthcare 62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
– –
-9,623
27
– –
-200,000
28
– –
-464
29
– –
-3,750
30
– –
-2,766,152
31
– –
-240,597
32
– –
-106,700
1
2